Related Experiment Videos
[Vaccinations and systemic diseases. Vaccinations and immunosuppression]
1Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude Bernard, Paris.
Annales De Medecine Interne
|December 16, 1998
Summary
Vaccination does not appear to trigger systemic disease flares. However, careful consideration of risks and benefits is crucial for immunocompromised individuals, especially regarding vaccine types and schedules.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Immunocompromised individuals face risks of adverse events and suboptimal responses to vaccines.
- Live attenuated vaccines pose risks of post-immunization complications in severely immunocompromised persons.
- Killed/inactivated vaccines have no contraindications but may elicit reduced immune responses.
Purpose of the Study:
- To evaluate the hypothesis that vaccination triggers systemic disease flare-ups or onset.
- To review vaccination considerations in immunocompromised populations.
- To assess vaccine efficacy and safety in HIV-infected individuals.
Main Methods:
- Literature analysis of vaccination in immunocompromised patients.
- Review of risks associated with live, attenuated, and inactivated vaccines.
- Examination of vaccine response modifications and HIV-specific considerations.
Main Results:
- Data analysis does not support the hypothesis of vaccination-induced systemic disease flares.
- Live vaccines carry risks for severely immunocompromised individuals.
- Reduced immune responses to inactivated vaccines necessitate dose or schedule adjustments, though not systematically evaluated.
Conclusions:
- Vaccination is vital for preventing infectious diseases in immunocompromised individuals, but risks must be managed.
- Further systematic evaluation is needed for modified vaccine schedules in immunocompromised populations.
- Live vaccines remain recommended for HIV+ children in developing countries due to high disease prevalence.